Ан Сунг Гви

 

 

 

 Профессор Отделения хирургии,

Система здравоохранения при университете Ёнсе, клиника Кангнам Северанс, Сеул, Южная Корея

 

 

 

 

 

Образование

  • Март 1997 — Февраль 2004 

Диплом бакалавра, медицинский колледж при университете Ёнсе

  • Март 2007 — Февраль 2012 

 Диплом магистра медицинских наук, медицинский колледж при университете Ёнсе

  • Сентябрь 2012 — Февраль 2019 

 Кандидат медицинских наук, медицинский колледж при университете Ёнсе

 

Лицензия 

  • 1991 — Лицензирован на медицинскую практику в Корее #81709
  • 1996 — Комитет общей хирургии #6239

 

Обучение и трудовая деятельность Training & Employment

  • Март 2004 — Февраль 2005 

Интернатура, клиника Синчон Северанс, университет Ёнсе, Сеул, Южная Корея

  • Март 2005 — Февраль 2009 

 Резидентура, клиника Синчон Северанс, отделение хирургии, университет Ёнсе, Сеул, Южная Корея

  • Mай 2009 – Апрель 2012 

 Военный врач, военный госпиталь Ёнгджу, Ёнгджу, Кёнггидо

  • Май 2012 – Февраль 2014 

 Стажер, отделение хирургии клиника Кангнам Северанс, университет Ёнсе, Сеул, Южная Корея

  • Март 2014 – Февраль 2016   

 Клинический доцент хирургического отделения Кангнам Северанс, университет Ёнсе, Сеул, Южная Корея

  • Март 2016 – по настоящее время 

 Профессор хирургического отделения клиники Кангнам Северанс, университет Ёнсе, Сеул, Южная Корея

 

Библиография

Основные публикации

    • Cha YJ*, Ahn SG*, Bae SJ, Yoon CI, Seo J, Jung WH, Son EJ, Jeong J. Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis. Breast Cancer Res Treat. 2018 Sep;171(2):295-302.
    • Ahn SG*, Cha YJ*, Bae SJ, Yoon C, Lee HW, Jeong J. Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer. BMC Cancer. 2018 Mar 24;18(1):320.
    • Cho Y, Kang HG, Kim SJ, Lee S, Jee S, Ahn SG, Kang MJ, Song JS, Chung JY, Yi EC, Chun KH. Post-translational modification of OCT4 in breast cancer tumorigenesis. Cell Death Differ. 2018 Nov;25(10):1781-1795.
    • Lee SA, Lee HM, Lee HW, Yang BS, Park JT, Ahn SG, Jeong J, Kim SI. Risk Factors for a False-Negative result of Sentinel Node Biopsy in Patients with Clinically Node negative Breast Cancer. Cancer Res Treat. 2017 Jul 31. [Epub ahead of print]
    • Yoo TK, Kim SW, Kang E, Ahn SG, Hwang KT, Kim SK, Woo SU, Shin HJ, Song YJ, Jung EJ, Chang MC, Lee I, Park WC; Korean Breast Cancer Society. The Practice Patterns and Perceptions of Korean Surgeons Regarding Margin Status after Breast-Conserving Surgery. J Breast Cancer. 2017 Dec;20(4):400-403.
    • Yang KM, Bae E, Ahn SG, Pang K, Park Y, Park J, Lee J, Ooshima A, Park B, Kim J, Jung Y, Takahashi S, Jeong J, Park SH, Kim SJ. Co-chaperone BAG2 Determines the Pro-oncogenic Role of Cathepsin B in Triple-Negative Breast Cancer Cells. Cell Rep. 2017 Dec 5;21(10):2952-2964.
    • Kyeong S, Cha YJ, Ahn SG, Suh SH, Son EJ, Ahn SJ. Subtypes of breast cancer show different spatial distributions of brain metastases. PLoS One. 2017 Nov 20;12(11):e0188542.
    • Ahn SG, Bae SJ, Yoon C, Cha YJ, Lee HW, Lee SA, Jeong J. Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay. PLoS One. 2017 Nov 8;12(11):e0187679
    • Jo SJ, Park PG, Cha HR, Ahn SG, Kim MJ, Kim H, Koo JS, Jeong J, Park JH, Dong SM, Lee JM. Cellular inhibitor of apoptosis protein 2 promotes the epithelial-mesenchymal transition in triple-negative breast cancer cells through activation of the AKT signaling pathway. Oncotarget. 2017 Aug 12;8(45):78781-78795.
    • Park JM, Bae SJ, Yoon C, Lee HS, Lee HW, Ahn SG*, Lee SA, Jeong J. Comparison of patients with small (≤2 cm) breast cancer according to adherence to breast screening program. PLoS One. 2017 Nov 2;12(11):e0186988.
    • Lee S, Park IH, Park S, Sohn J, Jeong J, Ahn SG, Lee IJ, Lee HK, Lee SA, Park W, Lee KH, Kim SW, Han SA, Jung KH, Son BH. Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea. J Breast Cancer. 2017 Sep;20(3):228-233.
    • Lee JH, Jung SM, Yang KM, Bae E, Ahn SG, Park JS, Seo D, Kim M, Ha J, Lee J, Kim JH, Kim JH, Ooshima A, Park J, Shin D, Lee YS, Lee S, van Loo G, Jeong J, Kim SJ, Park SH. A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1. Nat Cell Biol. 2017 Oct;19(10):1260-1273.
    • Lee SA, Lee HM, Lee HW, Yang BS, Park JT, Ahn SG, Jeong J, Kim SI. Risk Factors for a False-Negative result of Sentinel Node Biopsy in Patients with Clinically Node negative Breast Cancer. Cancer Res Treat. 2017 Jul 31. doi: 10.4143/crt.2017.089.
    • Lee JJB, Choi J, Ahn SG, Jeong J, Lee IJ, Park K, Kim K, Kim JW. In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost. Radiat Oncol J. 2017 Jun;35(2):121-128
    • Ahn SG, Lee JH, Lee HW, Jeon TJ, Ryu YH, Kim KM, Sohn J, Yun M, Lee SA, Jeong J, Kim SI. Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer. PLoS One. 2017 Apr 18;12(4):e0175048.
    • Lee HW, Lee HM, Choi SE, Yoo H, Ahn SG, Lee MK, Jeong J, Jeong WH. The Prognostic Impact of Early Change in Standardized Uptake Value of 18F-fluorodeoxy-glucose Positron Emission Tomography after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients. J Nucl Med. Aug;57(8):1183-8.
    • Kim HJ*, Ahn SG*, Lee HM, Park JT, Han K, Lee SA, Jeong J. Metastasis-Free Interval Is Closely Related to Tumor Characteristics and Has Prognostic Value in Breast Cancer Patients with Distant Relapse. J Breast Cancer. 2015;18(4):371-7.
    • Chong JU*, Ahn SG*, Lee HM, et al. Local control of brain metastasis: treatment outcome of focal brain treatments in relation to subtypes. J Breast Cancer. 2015 Mar;18(1):29-35.
    • Ahn SG*, Park JT*, Lee HM, et al. Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden. Breast Cancer Res. 2014;16(6):502.
    • Ahn SG*, Kim SH*, Lee HM, et al. Survival benefit of zoledronic Acid in postmenopausal breast cancer patients receiving aromatase inhibitors. J Breast Cancer. 2014 Dec;17(4):350-5.
    • Lee HD*, Ahn SG*, Lee SA, et al. Prospective evaluation of the feasibility of sentinel lymph node biopsy in breast cancer patients with negative axillary conversion after neoadjuvant chemotherapy. Cancer Res Treat. 2015 Jan;47(1):26-33.
    • Ahn SG, Lee M, Jeon TJ, et al. [18F]-Fluorodeoxyglucose Positron Emission Tomography Can Contribute to Discriminate Patients with Poor Prognosis in Hormone Receptor-Positive Breast Cancer. PLoS One. 2014 Aug 28;9(8):e105905.
    • Ahn SG, Lee HM, Lee SA, et al. Long-term survival analysis of korean breast cancer patients at a single center: improving outcome over time. Yonsei Med J. 2014 Sep;55(5):1187-95.
    • Ahn SG, Lee SA, Lee HW, et al. In vitro chemoresponse assay based on the intrinsic subtypes in breast cancer. Jpn J Clin Oncol. 2014 Jul;44(7):624-31.
    • Ahn SG, Lee HM, Lee HW, et al. Prognostic discrimination using a 70-gene signature among patients with estrogen receptor-positive breast cancer and an intermediate 21-gene recurrence score. Int J Mol Sci. 2013 Dec 4;14(12):23685-99.
    • Cha C*, Ahn SG*, Lee HM, et al. Assessment of adjuvant trastuzumab-associated cardiac toxicity in korean patients with breast cancer: a single-center analysis. Oncology. 2013;85(4):228-34.
    • Ahn SG*, Dong SM*, Oshima A, et al. LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients. Breast Cancer Res Treat. 2013 Aug;141(1):89-99.
    • Ahn SG, Jeon TJ, Lee SD, et al. A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function. Eur J Surg Oncol. 2013 Sep;39(9):964-73.
    • Ahn SG, Lee HM, Cho SH, et al. Prognostic factors for patients with bone-only metastasis in breast cancer. Yonsei Med J. 2013 Sep;54(5):1168-77.
    • Ahn SG, Lee HM, Cho SH, et al. The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence. PLoS One. 2013 May 22;8(5):e63510.
    • Hwang SH, Jeong J, Ahn SG, Lee HM, Lee HD. Clinical outcomes of ductal carcinoma in situ of the breast treated with partial mastectomy without adjuvant radiotherapy. Yonsei Med J. 2012 May;53(3):537-42.
    • Lee SA, Hwang SH, Ahn SG, Lee HM, Jeong J, Lee HD. Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients. Breast Cancer Res Treat. 2011 Dec;130(3):863-70.
    • Ahn SG, Kim SH, Jeon TJ, Cho HJ, Choi SB, Yun MJ, Lee JD, Kim KS. The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas. J Gastrointest Surg. 2011 Nov;15(11):2044-52. Epub 2011 Sep 9.
    • Ahn SG, Jeong J, Choi SK, Hwang SH, Lee SA, Jung WH, Lee HD. Correlation of Early Systemic Recurrence with In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay in Stage II and III Breast Cancer Patients Treated with Doxorubicin-Based Chemotherapy. J Breast Cancer. 2011 Feb;14(Suppl 1):S50-S56. Korean
    • Choi SK, Jeong J, Lee SA, Hwang SH, Ahn SG, Jung WH, Lee HD. Heterogeneous Chemosensitivity of Breast Cancer Determined by Adeonsine Triphosphate Based Chemotherapy Response Assay. J Breast Cancer. 2010 Jun;13(2):180-6. Korean.
    • Ahn SG, Lee KS, Kim S. The Prognostic Factors for Tumor Metastasis to Bone from Breast Cancer and Survival for Breast Cancer Patients after Bone Metastasis. J Breast Cancer. 2008 Dec; 11(4):187-93. Korean.
    • Oh JT, Choi SH, Ahn SG, Kim MJ, Yang WI, Han SJ. Vulvar lipomas in children: an analysis of 7 cases. J Pediatr Surg. 2009 Oct;44(10):1920-3.

Обзорные статьи

  • Ahn SG, Kim SJ, Kim C, Jeong J. Molecular Classification of Triple-Negative Breast Cancer. J Breast Cancer. 2016 Sep;19(3):223-230.
  • Ahn SG, Jeong J, Hong S, et al. Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer. J Pathol Transl Med. 2015;49(5):355-63.

Отправка заявки